Analysts See $0.15 EPS for DLH Holdings Corp. (DLHC) as of May, 9

April 17, 2018 - By Damon Whitfield

DLH Holdings Corp. (NASDAQ:DLHC) Corporate Logo

On May, 9 is anticipated DLH Holdings Corp. (NASDAQ:DLHC)’s earnings report, Faxor reports. Last year’s EPS was $0.08, while now analysts expect change of 87.50 % up from current $0.15 EPS. DLHC’s profit could be $1.78 million with 10.18 P/E in case $0.15 EPS is revealed. After $0.04 EPS was revealed last quarter, analysts now see EPS growth of 275.00 % for DLH Holdings Corp.. On during the last trading session the stock increased $0.03 or 0.49%, reaching $6.11.Currently DLH Holdings Corp. is uptrending after 5.74% change in last April 17, 2017. DLHC has 2,945 shares volume. DLHC underperformed the S&P500 by 5.81%.

DLH Holdings Corp. (NASDAQ:DLHC) Ratings Coverage

Total analysts of 2 have positions in DLH Holdings (NASDAQ:DLHC) as follows: 2 rated it a “Buy”, 0 with “Sell” and 0 with “Hold”. The positive are 100%. Since December 6, 2017 according to StockzIntelligence Inc DLH Holdings has 2 analyst reports. The stock rating was maintained by Canaccord Genuity with “Buy” on Wednesday, December 6. On Thursday, December 7 Noble Financial maintained the shares of DLHC in report with “Buy” rating.

DLH Holdings Corp. provides healthcare and social services in the United States.The firm is valued at $72.60 million. It offers defense and veterans?? health solutions, including case management, physical and behavioral health examinations, and medical administration and logistics services.The P/E ratio is 678.89. The firm also provides a range of human services and solutions, which consists of educational and environmental support services for the underserved children and youth comprising health, nutritional, parental, and behavioral services; and IT system architecture design, migration plan, and ongoing maintenance services.

DLH Holdings Corp. (NASDAQ:DLHC) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.